TrialStem cell research & therapy2026

Mesenchymal stromal cells as add-on therapy to anti-CD25 antibodies for treating gastrointestinal-involved steroid-refractory acute graft-versus-host disease: a multicenter, single-arm, pivotal clinical trial.

Yawei Zheng et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.